DOI QR코드

DOI QR Code

Purification and Characterization of Anti-Coagulant Activity Fraction from Persimmon Stem

감꼭지로부터 혈액응고저해물질의 정제와 특성

  • Published : 2003.12.01

Abstract

Persimmon has been considered to have therapeutic values for various diseases in Korea. Dried persimmon has been applied to wounded parts for anti-inflammatory and analgesic activities. Anti-coagulant fraction from Persimmon stem was purified through gel filtration, phenyl Sepharose, DEAE-Sephadex and additional gel filtration column chromatographies. Its molecular weight was estimated to be 130,000 ∼ 180,000. By element analysis, its main components were C, H, and O. The anti -coagulant was heat- stable and completely inhibited after periodate oxidation, indicating that it was a complex carbohydrate.

감은 예전부터 민간약으로 종기나 염증질환, 치질에 곶감을 이겨 붙였고 부스럼이나 화상에는 불에 말린 감을 바르면 통증을 멎게 하고 새살을 돋게 하는 효능이 있고 고혈압을 예방하고 동맥경화에 효과가 있는 성분이 있다고 알려져 있다. 사람의 plasma에서 thrombin time(TT)를 사용한 혈액 응고저해 assay를 이용하여 감꼭지에서 혈액응고저해물질을 겔여과크로마토그래피, 소수성크로마토그래피, 음이온교환크로마토그래피, 또 한번의 겔여과크로마토그래피를 통해 정제했다. 감꼭지의 혈액응고저해물질은 분자량이 130,000 ∼ 180,000으로 거대 분자이고 구성분은 C, H, O로 구성되어 있고 periodate oxidation시 거의 활성이 소멸되고 열에 안정하며 주로 glucose와 galactose로 구성된 다당류로 추정된다.

Keywords

References

  1. Uchida S, Ozaki M, Akashi T, Yamashita K, Niwa M, Taniyama K. 1995. Effects of (-)-epigallocatechin-3-Ogallate (green tea tannin) on the life span of stroke-prone spontaneously hypertensive rats. Clin Exp Pharmacol Physiol 22: 302-323. https://doi.org/10.1111/j.1440-1681.1995.tb02004.x
  2. Kameda K, Takaku T, Okuda H, Kimura Y, Okuda T, Haitian T, Agata I, Arichi S. 1987. Inhibitory effects of various flavonoids isolated from leaves of persimmon on angiotensin-converting enzyme activity. J Natl Prod 50: 680-683. https://doi.org/10.1021/np50052a017
  3. Okonogi T, Hattori Z, Ogiso A, Mitsui S. 1979. Detoxification by persimmon tannin of snake venoms and bacterial toxins. Toxicon 17: 524-527. https://doi.org/10.1016/0041-0101(79)90287-3
  4. Hibasami H, Achiwa Y, Fujikawa T, Komiya T. 1996. Induction of programmed cell death (apoptosis) in human lymphoid leukemia cells by catechin compounds. Anticancer Res 16: 1943-1946.
  5. Stubbs MT, Oschkinat H, Mayr I, Huber R, Angliker H, Stone SR, Bode W. 1992. The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem 206: 187-195. https://doi.org/10.1111/j.1432-1033.1992.tb16916.x
  6. Tsiang M, Lentz SR, Sadler JE. 1992. Functional domains of membrane-bound human thrombomodulin. EGF-like domains four to six and the serine/threonine-rich domain are required for cofactor activity. J Biol Chem 267: 6164-6170.
  7. Dahlback B. 2000. Blood coagulation. Lancet 355: 1627-1632. https://doi.org/10.1016/S0140-6736(00)02225-X
  8. Yao SK, McNatt J, Anderson HV, Eidt J, Cui KX, Golino P, Glas-Greenwalt P, Maraganore J, Buja LM, Willerson JT. 1992. Thrombin inhibition enhances tissue-type plasminogen activator-induced thrombolysis and delays reocclusion. Am J Physiol 262: H374-379.
  9. Weksler BB, Ley CW, Jaffe EA. 1978. Stimulation of endothelial cell prostacyclin production by thrombin, trypsin, and the ionophore A 23187. J Clin Invest 62: 923-930. https://doi.org/10.1172/JCI109220
  10. Cunningham DD, Wagner SL, Farrell DH. 1992. Regulation of protease nexin-1 activity by heparin and heparan sulfate. Adv Exp Med Biol 313: 297-306. https://doi.org/10.1007/978-1-4899-2444-5_29
  11. Olson STI, Bjork R, Sheffer PA, Craig J, Shore D, Choay J. 1992. Role of the antithrombin-binding pentasaccharide in heparin acceleration of antithrombin-proteinase reactions. Resolution of the antithrombin conformational change contribution to heparin rate enhancement. J Biol Chem 267: 12528-12538.
  12. Orbe J, Montes R, Zabalegui N, Peruz-Ruiz A, Paramo JA. 1999. Evidence that heparin but not hirudin reduces PAI-1 expression in cultured human endothelial cells. Thromb Res 94: 137-142. https://doi.org/10.1016/S0049-3848(98)00203-5
  13. Trunen P, Mikkola T, Ylikorkala O, Viinikka L. 1996. Hirudin stimulates prostacyclin but not endothelin-1 production in cultured human vascular endothelial cells. Thromb Res 81: 635-639. https://doi.org/10.1016/0049-3848(96)00039-4
  14. Markwardt F. 2002. Hirudin as alternative anticoagulant-a historical review. Semin Thromb Hemost 28: 405-414. https://doi.org/10.1055/s-2002-35292
  15. McClanahan TB, Ignasiak DP, Juneau P, Finkle C, Winocour PD, Gallagher KP. 1999. Antithrombotic effects of BCH 2763, a new direct thrombin inhibitor, in a canine model of venous thrombosis. J Thromb Thrombolysis 7: 301-306. https://doi.org/10.1023/A:1008987211850
  16. Giardino EC, Costanzo MJ, Kauffman JA, Li QS, Maryanoff BE, Andrade-Gordon P. 2000. Antithrombotic properties of RWJ-50353, a potent and novel thrombin inhibitor. Thromb Res 98: 83-93.
  17. McClanahan TB, Hicks GW, Morrison AL, Peng YW, Janiczek-Dolphin N, Mertz TE, Sullivan ME, Morser J, Juneau PL, Leadley R. 2001. The antithrombotic effects of CI-1031 (ZK-807834) and enoxaparin in a canine electrolytic injury model of arterial and venous thrombosis. Eur J Pharmacol 432:187-194. https://doi.org/10.1016/S0014-2999(01)01090-1
  18. Lee YC, Sa YS, Jeong C, Suh KG, Choi HS. 2001. Anticoagulating activity of persimmon and its processed foods. J Korean Soc Food Sci Nutr 30: 949-953.

Cited by

  1. Change in the Polyphenol Content of Cheongdobansi Persimmon Fruit during Development vol.18, pp.1, 2011, https://doi.org/10.11002/kjfp.2011.18.1.013
  2. The anticoagulant fraction from the leaves ofDiospyros kaki L. has an antithrombotic activity vol.28, pp.6, 2005, https://doi.org/10.1007/BF02969356
  3. Whitening Effect of Extracts and Fractions from Diospyros kaki calyx vol.23, pp.3, 2013, https://doi.org/10.5352/JLS.2013.23.3.383
  4. 옥발에서 항응고물질의 정제와 특성 vol.33, pp.8, 2003, https://doi.org/10.3746/jkfn.2004.33.8.1262
  5. 시체(柿蒂)의 in vitro와 in vivo 항혈전 효능 연구 vol.26, pp.4, 2003, https://doi.org/10.6116/kjh.2011.26.4.139
  6. 어린 감 과실 분말 첨가가 쌀쿠키의 품질특성에 미치는 영향 vol.24, pp.8, 2003, https://doi.org/10.11002/kjfp.2017.24.8.1060